Showing results (201-210 of 319) with videos related to

Sort By:
Pageof 32
Journal of Hepatology|November 28, 2006
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient miceElena Zamara, Sara Galastri, Sara Aleffi, et al.
Clinical Science (London, England : 1979)|May 2, 2012
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitisSara Galastri, Elena Zamara, Stefano Milani, et al.
Journal of Hepatology|December 16, 2003
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cellsElena Zamara, Erica Novo, Fabio Marra, et al.
Circulation Research|July 16, 2005
CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitorsPaola Romagnani, Francesco Annunziato, Francesco Liotta, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 10, 2005
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cellsRoberto G Romanelli, Ilaria Petrai, Gaia Robino, et al.
Molecular Cancer Therapeutics|February 22, 2023
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in CholangiocarcinomaGiulia Anichini, Chiara Raggi, Mirella Pastore, et al.
Gastroenterology|October 1, 2003
The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis CAndrea Bonacchi, Ilaria Petrai, Raffaella M S Defranco, et al.
Gut|September 4, 2014
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinomaElisabetta Rovida, Giovanni Di Maira, Ignazia Tusa, et al.
International Journal of Molecular Sciences|September 27, 2025
The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic CholangiocarcinomaErwin Gäbele, Isabella Gigante, Mirella Pastore, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2015
Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitisMargarita Pizarro, Nancy Solís, Pablo Quintero, et al.
Pageof 32